Harnessing the incretin system beyond glucose control: potential cardiovascular benefits of GLP-1 receptor agonists in type 2 diabetes.

Abstract:

:The management of type 2 diabetes continues to evolve as new data emerge. Although glycaemic control is still important, other risk factors--such as hypertension, dyslipidaemia and obesity--must also be addressed in order to reduce the long-term risks of cardiovascular complications and mortality. In this context, targeting the incretin system, and glucagon-like peptide-1 (GLP-1) in particular, has generated much interest. GLP-1 is released from the gut in response to food ingestion and plays a crucial role in glucose homeostasis. GLP-1 receptors are expressed in the heart and vasculature, prompting evaluation of their physiological role and pharmacological stimulation, both in healthy and disease states. These studies indicate that GLP-1 and GLP-1-based therapies appear to have direct, beneficial effects on the cardiovascular system, in addition to their glucose-lowering properties, such as modulation of blood pressure, endothelial function, and myocardial contractility. Intriguingly, some of these effects appear to be independent of GLP-1 receptor signalling. Data from clinical studies of the GLP-1 receptor agonists, exenatide and liraglutide on cardiovascular risk factors, in patients with type 2 diabetes are also promising and the results from prospective studies to assess cardiovascular outcomes are eagerly awaited.

journal_name

Diabetes Metab

journal_title

Diabetes & metabolism

authors

Cariou B

doi

10.1016/j.diabet.2012.04.003

subject

Has Abstract

pub_date

2012-10-01 00:00:00

pages

298-308

issue

4

eissn

1262-3636

issn

1878-1780

pii

S1262-3636(12)00078-X

journal_volume

38

pub_type

杂志文章,评审
  • Insulin therapy and GH-IGF-I axis disorders in diabetes: impact of glycaemic control and hepatic insulinization.

    abstract::In Type 1 diabetes, high circulating growth hormone (GH) in conjunction with low plasma insulin-like growth factor-I (IGF-I) is indicative of a hepatic GH-resistance profile since the liver is the main source of circulating IGF-I. The reduction in specific growth hormone binding protein (GHBP), corresponding to the ex...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章,评审

    doi:

    authors: Hanaire-Broutin H,Sallerin-Caute B,Poncet MF,Tauber M,Bastide R,Rosenfeld R,Tauber JP

    更新日期:1996-07-01 00:00:00

  • Parent-child physical activity relationships in 12-year old French students do not depend on family socioeconomic status.

    abstract:OBJECTIVES:Regular physical activity (PA) in young needs to be promoted to prevent obesity and subsequent diabetes. Influences of parental PA on adolescents' activity level have been studied with discordant results and the effect of socioeconomic status (SES) on these relationships is not clarified. METHODS:Cross-sect...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/s1262-3636(07)70129-5

    authors: Wagner A,Klein-Platat C,Arveiler D,Haan MC,Schlienger JL,Simon C

    更新日期:2004-09-01 00:00:00

  • Relationship between the hyperinsulinemic-euglycaemic clamp and a new simple index assessing insulin sensitivity in overweight and obese postmenopausal women.

    abstract:OBJECTIVE:The purpose of this study was to compare assessment of insulin sensitivity from hyperinsulinemic euglycaemic (HIEG) clamp with indexes derived from fasting and oral glucose tolerance test (OGTT). SUBJECTS AND METHODS:Cross-sectional study with 107 sedentary non-diabetic overweight and obese postmenopausal (B...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/j.diabet.2007.02.004

    authors: Bastard JP,Vandernotte JM,Faraj M,Karelis AD,Messier L,Malita FM,Garrel D,Prud'homme D,Rabasa-Lhoret R

    更新日期:2007-09-01 00:00:00

  • Type 1 diabetes control and pregnancy outcomes in women treated with continuous subcutaneous insulin infusion (CSII) or with insulin glargine and multiple daily injections of rapid-acting insulin analogues (glargine-MDI).

    abstract:AIM:The best way to treat pregnant patients who have type 1 diabetes is still unclear. For this reason, the present study compared metabolic control and maternal-fetal outcomes in patients treated with continuous subcutaneous infusions of rapid-acting insulin analogues (CSII) or with insulin glargine and multiple daily...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.diabet.2011.02.002

    authors: Bruttomesso D,Bonomo M,Costa S,Dal Pos M,Di Cianni G,Pellicano F,Vitacolonna E,Dodesini AR,Tonutti L,Lapolla A,Di Benedetto A,Torlone E,Italian Group for Continuous Subcutaneous Insulin Infusion in Pregnancy.

    更新日期:2011-11-01 00:00:00

  • [From external to implantable insulin pump, can we close the loop?].

    abstract::The project to finalize a 'closed loop' insulin delivery according to blood glucose level, i.e. an implanted artificial beta cell, is born from the development of the first miniaturized portable insulin pumps during the 1970s. Continuous improvements in micro-electronics, as well as in the development of biomaterials ...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:

    authors: Renard E,Costalat G,Bringer J

    更新日期:2002-09-01 00:00:00

  • Managing the manager: gut microbes, stem cells and metabolism.

    abstract::One major discovery of the last decade in the field of metabolic diseases is that the microorganisms comprising the gut microbiota are now considered a metabolic "organ", modulating multiple functions of the host, such as intestinal immune system maturation, adiposity, cardiac metabolism, liver triglyceride storage, a...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章,评审

    doi:10.1016/j.diabet.2013.12.004

    authors: Serino M,Blasco-Baque V,Nicolas S,Burcelin R

    更新日期:2014-06-01 00:00:00

  • Metabolic effects of SGLT-2 inhibitors beyond increased glucosuria: A review of the clinical evidence.

    abstract::Sodium-glucose cotransporter type 2 (SGLT-2) inhibitors (canagliflozin, dapagliflozin, empagliflozin) are new glucose-lowering agents that exert their therapeutic activity independently of insulin by facilitating glucose excretion through the kidneys. However, this simple renal mechanism that results in sustained gluc...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章,评审

    doi:10.1016/S1262-3636(14)72689-8

    authors: Scheen AJ,Paquot N

    更新日期:2014-12-01 00:00:00

  • The association of type 2 diabetes and insulin resistance/secretion with persistent organic pollutants in two First Nations communities in northern Ontario.

    abstract:AIMS:Recent evidence suggests an association between persistent organic pollutants (POPs) and type 2 diabetes. In two First Nations communities where wild food is consumed by a large portion of the population, we compared pollutants in plasma between diabetic and non-diabetic individuals, and investigated the strength ...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/j.diabet.2013.01.006

    authors: Pal S,Blais JM,Robidoux MA,Haman F,Krümmel E,Seabert TA,Imbeault P

    更新日期:2013-12-01 00:00:00

  • Adipose tissue is influenced by hypoxia of obstructive sleep apnea syndrome independent of obesity.

    abstract:AIMS:Obstructive sleep apnea syndrome (OSAS) is associated with increased cardiovascular risk and diabetes independent of obesity. We investigated whether adipose tissue dysfunction is exacerbated due to increased tissue hypoxia. METHODS:Adipose tissue (AT) oxygenation was measured with a Clarke-type electrode (pATO2)...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/j.diabet.2016.12.002

    authors: Thorn CE,Knight B,Pastel E,McCulloch LJ,Patel B,Shore AC,Kos K

    更新日期:2017-06-01 00:00:00

  • Adiponectin: an update.

    abstract::The discoveries of leptin and adiponectin were breakthroughs in the field of metabolic diseases. Adipose cells produce both proteins and release them into the circulation. Leptin acts as a fundamental signal for the brain to modulate food intake as a function of energy status. Loss of leptin function results in obesit...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章,评审

    doi:10.1016/j.diabet.2007.08.002

    authors: Guerre-Millo M

    更新日期:2008-02-01 00:00:00

  • Pulse pressure strongly predicts cardiovascular disease risk in patients with type 2 diabetes from the Swedish National Diabetes Register (NDR).

    abstract:OBJECTIVES:To analyze pulse pressure (PP) as a risk predictor for coronary heart disease (CHD), stroke and cardiovascular disease (CVD; CHD and/or stroke) in type 2 diabetic patients. METHODS:A total of 11,128 female and male type 2 diabetic patients with known baseline PP values and no CVD, aged 50-74 years, were fol...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/j.diabet.2009.04.010

    authors: Nilsson PM,Cederholm J,Eeg-Olofsson K,Eliasson B,Zethelius B,Gudbjörnsdóttir S,Swedish National Diabetes Register (NDR).

    更新日期:2009-12-01 00:00:00

  • [Macronutrients, fat mass, fatty acid flux and insulin sensitivity].

    abstract::Obesity and visceral or upper body fat distribution, have a major impact on insulin sensitivity. There is strong evidence to suggest that free fatty acids (FFA) contribute to the pathogenesis of insulin resistance and the metabolic syndrome. Increased FFA release from adipose tissue or failure of FFA using tissues to ...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章,评审

    doi:

    authors: Ziegler O,Quilliot D,Guerci B,Drouin P

    更新日期:2001-04-01 00:00:00

  • Multicenter randomized evaluation of a nutritional education software in obese patients.

    abstract:OBJECTIVE:To study the efficacy of the nutritional education software, Nutri-Expert, in the management of obese adult patients. MATERIAL AND METHODS:Two groups of obese patients were followed up over one year in a randomized study: the first group received close traditional management (seven nutritional visits over th...

    journal_title:Diabetes & metabolism

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:

    authors: Turnin MC,Bourgeois O,Cathelineau G,Leguerrier AM,Halimi S,Sandre-Banon D,Coliche V,Breux M,Verlet E,Labrousse F,Bensoussan D,Grenier JL,Poncet MF,Tordjmann F,Brun JM,Blickle JF,Mattei C,Bolzonella C,Buisson JC,Fabr

    更新日期:2001-04-01 00:00:00

  • Diabetes-related metabolic perturbations in cardiac myocyte.

    abstract::Although the pathogenesis of diabetic cardiomyopathy is poorly understood, recent evidence implicates perturbations in cardiac energy metabolism. Whereas mitochondrial fatty acid oxidation is the chief energy source for the normal postnatal mammalian heart, the relative contribution of glucose utilization pathways is ...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章,评审

    doi:10.1016/S1262-3636(08)70096-X

    authors: Feuvray D,Darmellah A

    更新日期:2008-02-01 00:00:00

  • Hyperosmolar nonketotic syndrome with hypernatremia: how can we monitor treatment?

    abstract::We report the case of a 62 year-old symptomatic patient with severe hyperglycemic hyperosmolality associated with hypernatremia. During treatment, the progressive decrease in serum tonicity, which resulted in the amelioration of the neurological symptoms, followed the decrease in serum glucose and mainly the corrected...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:

    authors: Liamis G,Gianoutsos C,Elisaf MS

    更新日期:2000-11-01 00:00:00

  • Role of fatty liver in the association between obesity and reduced hepatic insulin clearance.

    abstract:AIM:Hepatic insulin clearance (HIC) is important in regulating plasma insulin levels. Diminished HIC causes inappropriate hyperinsulinaemia, and both obesity and fatty liver (FL), which are known to decrease HIC, can be found either together in the same patient or on their own. The mechanism by which obesity reduces HI...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/j.diabet.2017.12.003

    authors: Matsubayashi Y,Yoshida A,Suganami H,Ishiguro H,Yamamoto M,Fujihara K,Kodama S,Tanaka S,Kaku K,Sone H

    更新日期:2018-03-01 00:00:00

  • [Modifications in myocardial energy metabolism in diabetic patients]].

    abstract::The capacity of cardiac myocyte to regulate ATP production to face any change in energy demand is a major determinant of cardiac function. Because FA is the main heart fuel (although the most expensive one in oxygen, and prompt to induce deleterious effects), this process is based on a balanced fatty acid (FA) metabol...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:

    authors: Grynberg A

    更新日期:2001-11-01 00:00:00

  • Prevalence of type 2 diabetes and impaired fasting glucose in the middle-aged population of three French regions - The MONICA study 1995-97.

    abstract:OBJECTIVES:The aim of this study was to determine the prevalence of type 2 diabetes and impaired fasting glucose (IFG) in a population-based sample of 3 508 subjects, aged 35-64 years, participating in the French MONICA population survey from 1995 to 1997 in three French regions: the Urban Community of Lille, the Bas-R...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章,多中心研究

    doi:

    authors: Gourdy P,Ruidavets JB,Ferrieres J,Ducimetiere P,Amouyel P,Arveiler D,Cottel D,Lamamy N,Bingham A,Hanaire-Broutin H,MONICA Study.

    更新日期:2001-06-01 00:00:00

  • When to treat a diabetic patient using an external insulin pump. Expert consensus. Société francophone du diabète (ex ALFEDIAM) 2009.

    abstract::For years, external insulin pumps have enjoyed proven efficacy as an intensive diabetes treatment to improve glycaemic control and reduce hypoglycaemia. Since the last ALFEDIAM guidelines in 1995, however, basal-bolus treatment using a combination of long- and short-acting insulin analogues have emerged and could chal...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章,实务指引

    doi:10.1016/j.diabet.2009.09.002

    authors: Lassmann-Vague V,Clavel S,Guerci B,Hanaire H,Leroy R,Loeuille GA,Mantovani I,Pinget M,Renard E,Tubiana-Rufi N,Société francophone du diabète (ex ALFEDIAM).

    更新日期:2010-02-01 00:00:00

  • Acute consequences of hypoglycaemia in diabetic patients.

    abstract::Strict glycaemic control is a major concern in many people with diabetes, hypoglycaemia being the most limiting factor in the daily management of patients with diabetes. Acute consequences of hypoglycaemic attacks are not precisely evaluated. Acute cardiovascular (CV) complications as myocardial ischaemia or stroke se...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章,评审

    doi:10.1016/S1262-3636(10)70471-7

    authors: Halimi S

    更新日期:2010-10-01 00:00:00

  • Acute renal failure in a diabetic patient.

    abstract::We report the case of a young insulin-dependent diabetic patient in whom acute renal failure led to detection of ureterohydronephrosis secondary to neurogenic bladder. The persistence of a high daily urine volume revealed diabetes insipidus, suggesting Wolfram syndrome, which was confirmed by the diagnosis of optic at...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:

    authors: Ankotché A,Delmas V,Larger E

    更新日期:1998-06-01 00:00:00

  • High prevalence of undiagnosed diabetes and high risk for diabetes using HbA1c criteria in middle-aged patients undergoing cataract surgery.

    abstract:AIM:This study assessed the prevalence of undiagnosed diabetes and a high risk for diabetes using glycated haemoglobin (HbA(1c)) values in middle-aged patients undergoing cataract surgery. METHODS:The study comprised 137 consecutive patients, aged 40 to 65 years, with no known diabetes undergoing cataract surgery at a...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/j.diabet.2012.10.009

    authors: Feldman-Billard S,Sedira N,Boelle PY,Poisson F,Héron E

    更新日期:2013-05-01 00:00:00

  • Vascular placental abnormalities and newborn death in a pregnant diabetic woman with familial partial lipodystrophy type 3: a possible role for peroxisome proliferator-activated receptor γ.

    abstract::The peroxisome proliferator-activated receptor protein gamma (PPARγ), a nuclear receptor involved in adipocyte differentiation, energy homoeostasis and fat storage, can lead, in rare cases of coding mutations, to familial partial lipodystrophy type 3 (FPLD3) with severe insulin resistance. PPARγ is also highly express...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/j.diabet.2012.02.012

    authors: Castell AL,Hiéronimus S,Lascols O,Fournier T,Fénichel P

    更新日期:2012-10-01 00:00:00

  • Low adiponectin levels at baseline and decreasing adiponectin levels over 10 years of follow-up predict risk of the metabolic syndrome.

    abstract:AIM:Adiponectin is the most abundant adipokine and may play a key role in the interplay between obesity, inflammation, insulin resistance and the metabolic syndrome (MetS). Thus, this large population-based cohort investigated whether adiponectin at baseline and/or a decrease in adiponectin during follow-up is associat...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/j.diabet.2016.07.027

    authors: Lindberg S,Jensen JS,Bjerre M,Frystyk J,Flyvbjerg A,Jeppesen J,Mogelvang R

    更新日期:2017-04-01 00:00:00

  • Anthropometric markers for detection of the metabolic syndrome in adolescents.

    abstract:OBJECTIVES:This study aimed to estimate, in a large group of Algerian adolescents, the prevalence of the metabolic syndrome (MetS), using four definitions (by Cook, De Ferranti, Viner and the IDF), and to test the validity of unique thresholds of waist circumference, waist/height ratio and BMI in screening for the MetS...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/j.diabet.2014.07.001

    authors: Benmohammed K,Valensi P,Benlatreche M,Nguyen MT,Benmohammed F,Pariès J,Khensal S,Benlatreche C,Lezzar A

    更新日期:2015-04-01 00:00:00

  • Factors related to CSII compliance.

    abstract::Many studies have demonstrated the metabolic efficacy of continuous subcutaneous insulin infusion (CSII) and particularly a reduction of glycaemic fluctuations in type 1 diabetic patients. Despite this benefit, many patients decide to discontinue the use of CSII. To determine the factors related to discontinuation of ...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/s1262-3636(07)70173-8

    authors: Ronsin O,Jannot-Lamotte MF,Vague P,Lassman-Vague V

    更新日期:2005-02-01 00:00:00

  • Relationship between achieved personalized glycaemic targets and monitoring of clinical events in elderly diabetic patients.

    abstract:AIM:Recent guidelines for the management of type 2 diabetes (T2DM) in the elderly recommend adjusting the therapeutic target (HbA1c) according to the patient's health. Our study aimed to explore the association between achieving the recommended personalized HbA1c target and the occurrence of major clinical events under...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.diabet.2016.05.008

    authors: Bucher S,Panjo H,Al-Salameh A,Bauduceau B,Benattar-Zibi L,Bertin P,Berrut G,Corruble E,Danchin N,Derumeaux G,Doucet J,Falissard B,Forette F,Hanon O,Ourabah R,Pasquier F,Piedvache C,Pinget M,Becquemont L,Ringa V,re

    更新日期:2017-02-01 00:00:00

  • Value and limitations of the Continuous Glucose Monitoring System in the management of type 1 diabetes.

    abstract::The CGMS (Continuous Glucose Monitoring System) is a portable device allowing continuous measuring of glucose. It provides recordings of at least 72 h, during which 288 measures/day are performed. Results are visualised in the form of a set of curves, illustrating the variations in blood glucose levels over time. The ...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章,评审

    doi:10.1016/s1262-3636(07)70258-6

    authors: Melki V,Ayon F,Fernandez M,Hanaire-Broutin H

    更新日期:2006-04-01 00:00:00

  • Seasonality and temperature effects on fasting plasma glucose: A population-based longitudinal study in China.

    abstract:AIMS:To examine the seasonality and effects of temperature on levels of fasting plasma glucose (FPG). METHODS:We collected health data from the Kailuan cohort study. FPG, blood pressure and individual information including age, gender, body mass index, smoking status, drinking habit, physical activities, income, work ...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/j.diabet.2016.01.002

    authors: Li S,Zhou Y,Williams G,Jaakkola JJ,Ou C,Chen S,Yao T,Qin T,Wu S,Guo Y

    更新日期:2016-09-01 00:00:00

  • Cannabinoid receptors as novel therapeutic targets for the management of non-alcoholic steatohepatitis.

    abstract::Prevalence of non-alcoholic steatohepatitis (NASH) rises steadily in Western countries with the obesity epidemic. NASH is associated with activation of liver fibrogenesis and predisposes to cirrhosis and associated morbi-mortality. The cannabinoid system is increasingly emerging as a crucial mediator of acute and chro...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/S1262-3636(08)74604-4

    authors: Mallat A,Lotersztajn S

    更新日期:2008-12-01 00:00:00